[Diffuse panbronchiolitis and erythromycin therapy].
Kudo
S
S
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001988:Bronchiolitis / Q000188:drug therapy* / Q000382:microbiology; D002455:Cell Division / Q000187:drug effects; D004917:Erythromycin / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism; D008214:Lymphocytes / Q000166:cytology; D008262:Macrophage Activation / Q000187:drug effects; D009504:Neutrophils / Q000378:metabolism; D011379:Prognosis
D000900:Anti-Bacterial Agents; D016209:Interleukin-8; D004917:Erythromycin